NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the ...

Synchron has been published in multiple peer-reviewed journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, and JNIS. Synchron is based in Brooklyn, New York with R&D ...

NEW YORK, January 13, 2025--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of ...

NEW YORK--(BUSINESS WIRE)--#BCI--Synchron, the endovascular brain-computer interface (BCI) company developing technology designed to restore functionality in patients with motor impairment, today ...

Synchron, a brain-computer interface (BCI) company, has released the first public demonstration of an individual using an iPad controlled entirely by thought, leveraging Apple’s built-in accessibility ...

Synchron, a brain-computer interface (BCI) company, has unveiled the roadmap to Chiral, which the company describes as “a foundation model of human cognitions, marking the emergence of Cognitive AI.” ...

NEW YORK — Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer. Haggstrom brings an extensive background in ...

NEW YORK–(BUSINESS WIRE)–Synchron, an implantable brain-computer interface (BCI) company, today announced the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from ...